| 1 | The 2024 APLAR Consensus on the Management of Lupus Nephritis | 0.8 | 19 | Citations (PDF) |
| 2 | Biosimilar Policies and Their Impact on Market Penetration of Adalimumab, Etanercept and Infliximab: A Policy Synthesis and Descriptive Analysis in 13 OECD Countries | 4.6 | 7 | Citations (PDF) |
| 3 | Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus Cohort | 1.6 | 2 | Citations (PDF) |
| 4 | Treatment strategy for systemic lupus erythematosus using belimumab as indicated by multi-omics analysis | 0.6 | 2 | Citations (PDF) |
| 5 | PSYCHOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS | 1.3 | 0 | Citations (PDF) |
| 6 | OVERWEIGHT AND OBESITY ARE KEY MODIFIABLE RISK FACTORS FOR ADVERSE OUTCOMES IN SLE PREGNANCIES | 1.3 | 0 | Citations (PDF) |
| 7 | Overweight and Obesity Are Key Modifiable Risk Factors for Adverse Outcomes in Systemic Lupus Erythematosus Pregnancies | 1.3 | 1 | Citations (PDF) |
| 8 | Addressing the challenge of global delays in diagnosis and treatment of systemic lupus erythematosus | 18.7 | 19 | Citations (PDF) |
| 9 | SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoring. | 1.5 | 18 | Citations (PDF) |
| 10 | Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | 0.8 | 9 | Citations (PDF) |
| 11 | Choosing to End African American Health Disparities in Patients With Systemic Lupus Erythematosus | 4.8 | 6 | Citations (PDF) |
| 12 | Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study | 6.8 | 31 | Citations (PDF) |
| 13 | Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus | 1.3 | 7 | Citations (PDF) |
| 14 | Association of HLA-DRB1 locus with treatment response to abatacept or TNF inhibitors in patients with seropositive rheumatoid arthritis | 2.8 | 8 | Citations (PDF) |
| 15 | Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus | 1.7 | 2 | Citations (PDF) |
| 16 | Exploring potential multiple molecular biomarkers that predict treatment response in patients with lupus nephritis | 2.8 | 8 | Citations (PDF) |
| 17 | Evaluating the Construct of Damage in Systemic Lupus Erythematosus | 2.3 | 23 | Citations (PDF) |
| 18 | Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study | 4.8 | 5 | Citations (PDF) |
| 19 | Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling | 2.3 | 2 | Citations (PDF) |
| 20 | Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes | 6.8 | 81 | Citations (PDF) |
| 21 | Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience | 6.8 | 6 | Citations (PDF) |
| 22 | Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort | 4.8 | 39 | Citations (PDF) |
| 23 | Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study | 15.0 | 21 | Citations (PDF) |
| 24 | Risk Factors for Pulmonary Arterial Hypertension in Patients With Systemic Lupus Erythematosus: A Systematic Review and Expert Consensus | 1.6 | 13 | Citations (PDF) |
| 25 | Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index | 2.3 | 21 | Citations (PDF) |
| 26 | Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort Study | 2.3 | 17 | Citations (PDF) |
| 27 | Human SLE variant NCF1-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages | 6.8 | 52 | Citations (PDF) |
| 28 | Novel susceptibility loci for steroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus. | 2.2 | 10 | Citations (PDF) |
| 29 | Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1) | 1.6 | 17 | Citations (PDF) |
| 30 | Risk factors for herpes zoster in Korean patients with rheumatoid arthritis treated with JAK inhibitor: a nested case–control study | 2.8 | 12 | Citations (PDF) |
| 31 | Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort | 6.8 | 87 | Citations (PDF) |
| 32 | The effect of 24-week belimumab treatment withdrawal followed by treatment restart in patients with SLE: an open-label, non-randomised 52-week study | 3.1 | 10 | Citations (PDF) |
| 33 | Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort | 6.8 | 21 | Citations (PDF) |
| 34 | ‘Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study | 3.1 | 39 | Citations (PDF) |
| 35 | Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study | 15.0 | 57 | Citations (PDF) |
| 36 | Biological insights into systemic lupus erythematosus through an immune cell-specific transcriptome-wide association study | 6.8 | 30 | Citations (PDF) |
| 37 | Predictive Factors for Renal Response in Lupus Nephritis: A Single-center Prospective Cohort Study. | 1.9 | 20 | Citations (PDF) |
| 38 | Safety and tolerability of bone marrow–derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humansLupus, 2022, 31, 1245-1253 | 1.0 | 21 | Citations (PDF) |
| 39 | Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort | 6.8 | 51 | Citations (PDF) |
| 40 | Global epidemiology of rheumatoid arthritis | 18.7 | 599 | Citations (PDF) |
| 41 | Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis | 14.9 | 271 | Citations (PDF) |
| 42 | Recurrent Neuropsychiatric Systemic Lupus Erythematosus Presenting with Primary Central Nervous System Lymphoma | 0.2 | 1 | Citations (PDF) |
| 43 | Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications | 2.3 | 30 | Citations (PDF) |
| 44 | Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria | 2.3 | 24 | Citations (PDF) |
| 45 | Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics | 6.8 | 31 | Citations (PDF) |
| 46 | Allele-Specific Quantification of HLA–DRB1 Transcripts Reveals Imbalanced Allelic Expression That Modifies the Amino Acid Effects in HLA–DRβ1 | 4.8 | 5 | Citations (PDF) |
| 47 | Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus | 6.8 | 156 | Citations (PDF) |
| 48 | Large-scale meta-analysis across East Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci | 6.8 | 146 | Citations (PDF) |
| 49 | Genetic variants shape rheumatoid arthritis-specific transcriptomic features in CD4+ T cells through differential DNA methylation, explaining a substantial proportion of heritability | 6.8 | 22 | Citations (PDF) |
| 50 | Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort. | 1.5 | 25 | Citations (PDF) |
| 51 | Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria datasetLupus, 2021, 30, 1283-1288 | 1.0 | 6 | Citations (PDF) |
| 52 | Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort | 4.8 | 23 | Citations (PDF) |
| 53 | Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and Apoptosis | 4.8 | 19 | Citations (PDF) |
| 54 | Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea | 2.8 | 18 | Citations (PDF) |
| 55 | Mortality in Korean Patients With Rheumatoid Arthritis. | 1.9 | 22 | Citations (PDF) |
| 56 | Clinical and Genetic Risk Factors Associated With the Presence of Lupus Nephritis. | 1.9 | 14 | Citations (PDF) |
| 57 | Excess mortality persists in patients with rheumatoid arthritis | 0.8 | 38 | Citations (PDF) |
| 58 | Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial | 6.8 | 222 | Citations (PDF) |
| 59 | Recent advances in understanding the genetic basis of systemic lupus erythematosus | 6.1 | 44 | Citations (PDF) |
| 60 | Intractable Progressive Cerebral Infarction with Multiple Atypical Aneurysms in Systemic Lupus Erythematosus | 0.2 | 0 | Citations (PDF) |
| 61 | Construction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus | 1.3 | 53 | Citations (PDF) |
| 62 | Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. | 4.8 | 61 | Citations (PDF) |
| 63 | Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach. | 2.3 | 29 | Citations (PDF) |
| 64 | Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index. | 4.8 | 36 | Citations (PDF) |
| 65 | Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus | 3.9 | 38 | Citations (PDF) |
| 66 | Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach | 6.8 | 70 | Citations (PDF) |
| 67 | Trial of Anifrolumab in Active Systemic Lupus Erythematosus | 25.2 | 1,199 | Citations (PDF) |
| 68 | Identifying damage clusters in patients with systemic lupus erythematosus | 0.8 | 12 | Citations (PDF) |
| 69 | An increased disease burden of autoimmune inflammatory rheumatic diseases in Korea | 2.0 | 45 | Citations (PDF) |
| 70 | P210 Efficacy and safety of filgotinib for patients with RA with inadequate response to methotrexate: FINCH1 primary outcome results | 1.5 | 1 | Citations (PDF) |
| 71 | Genome-wide association study in a Korean population identifies six novel susceptibility loci for rheumatoid arthritis | 6.8 | 33 | Citations (PDF) |
| 72 | Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.<i>Fas</i><sup>lpr</sup> mice | 8.4 | 20 | Citations (PDF) |
| 73 | Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort. | 4.8 | 21 | Citations (PDF) |
| 74 | Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk | 3.1 | 23 | Citations (PDF) |
| 75 | Association of HLA-G polymorphisms with systemic lupus erythematosus and correlation between soluble HLA‑G levels and the disease: a meta-analysis | 0.7 | 13 | Citations (PDF) |
| 76 | Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort. | 2.3 | 77 | Citations (PDF) |
| 77 | Associations between paraoxonase-1 and systemic lupus erythematosusLupus, 2019, 28, 1571-1576 | 1.0 | 5 | Citations (PDF) |
| 78 | Deletion at 2q14.3 is associated with worse response to TNF-α blockers in patients with rheumatoid arthritis | 3.1 | 2 | Citations (PDF) |
| 79 | Association between CD40 polymorphisms and systemic lupus erythematosus and correlation between soluble CD40 and CD40 ligand levels in the disease: a meta-analysisLupus, 2019, 28, 1452-1459 | 1.0 | 9 | Citations (PDF) |
| 80 | Clinical outcomes of patients with active rheumatoid arthritis with normal acute phase reactant values | 0.8 | 0 | Citations (PDF) |
| 81 | Causal association between body mass index and risk of rheumatoid arthritis: A Mendelian randomization study | 2.3 | 46 | Citations (PDF) |
| 82 | Increased risk of opportunistic infection in early rheumatoid arthritis | 0.8 | 21 | Citations (PDF) |
| 83 | Prevalence and predictors for sustained remission in rheumatoid arthritis | 1.6 | 14 | Citations (PDF) |
| 84 | Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians | 2.3 | 55 | Citations (PDF) |
| 85 | Associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis patients, and comparison of PON1 activity in patients and controls: a meta-analysis | 1.4 | 12 | Citations (PDF) |
| 86 | Development of a Paper-Based Viscometer for Blood Plasma Using Colorimetric Analysis | 5.3 | 24 | Citations (PDF) |
| 87 | Understanding HLA associations from SNP summary association statistics | 2.8 | 10 | Citations (PDF) |
| 88 | Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus. | 4.8 | 45 | Citations (PDF) |
| 89 | Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen | 1.5 | 11 | Citations (PDF) |
| 90 | Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort | 6.8 | 19 | Citations (PDF) |
| 91 | Development of the Asia Pacific Lupus Collaboration cohort | 0.8 | 39 | Citations (PDF) |
| 92 | Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study | 4.8 | 86 | Citations (PDF) |
| 93 | Vitamin D receptor FokI, TaqI, and ApaI polymorphisms and susceptibility to systemic lupus erythematosus: an updated meta-analysis | 1.4 | 11 | Citations (PDF) |
| 94 | Comparative efficacy and safety of biosimilar-infliximab and originator-infliximab in combination with methotrexate in patients with active rheumatoid arthritis: a meta-analysis of randomized controlled trials | 0.8 | 10 | Citations (PDF) |
| 95 | A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. | 2.2 | 32 | Citations (PDF) |
| 96 | Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil | 0.8 | 18 | Citations (PDF) |
| 97 | Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials | 1.4 | 13 | Citations (PDF) |
| 98 | Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials | 1.4 | 19 | Citations (PDF) |
| 99 | TYMS polymorphisms and responsiveness to or toxicity of methotrexate in rheumatoid arthritis | 0.7 | 7 | Citations (PDF) |
| 100 | Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus | 1.3 | 33 | Citations (PDF) |
| 101 | Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort | 1.5 | 49 | Citations (PDF) |
| 102 | Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. | 2.3 | 66 | Citations (PDF) |
| 103 | Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization | 2.0 | 53 | Citations (PDF) |
| 104 | A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea | 6.8 | 269 | Citations (PDF) |
| 105 | Glucocorticoids Are Associated with an Increased Risk for Vertebral Fracture in Patients with Rheumatoid Arthritis | 1.3 | 25 | Citations (PDF) |
| 106 | Non-aneurysmal subarachnoid hemorrhage in two patients with systemic lupus erythematosus: Case reports and literature review | 0.8 | 6 | Citations (PDF) |
| 107 | Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months | 0.8 | 10 | Citations (PDF) |
| 108 | Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta-analysis | 0.8 | 70 | Citations (PDF) |
| 109 | Clinical characteristics of multifocal osteonecrosis in Korean patients with rheumatic disease | 0.8 | 10 | Citations (PDF) |
| 110 | Association of CD8+ T-cells with bone erosion in patients with rheumatoid arthritis | 0.8 | 9 | Citations (PDF) |
| 111 | Associations between circulating macrophage migration inhibitory factor (MIF) levels and rheumatoid arthritis, and between MIF gene polymorphisms and disease susceptibility: a meta-analysis. | 1.8 | 25 | Citations (PDF) |
| 112 | Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach. | 2.3 | 22 | Citations (PDF) |
| 113 | Impact of anti-rheumatic treatment on cardiovascular risk in Asian patients with rheumatoid arthritis | 2.0 | 16 | Citations (PDF) |
| 114 | Productivity Loss of Rheumatoid Arthritis Patients according to the Their Stages of the Disease Activity Score | 1.9 | 2 | Citations (PDF) |
| 115 | Strategies for the safe use of non-steroidal anti-inflammatory drugs | 0.2 | 7 | Citations (PDF) |
| 116 | Vitamin D level and risk of systemic lupus erythematosus and rheumatoid arthritis: a Mendelian randomization | 1.4 | 46 | Citations (PDF) |
| 117 | Genetic variants in systemic lupus erythematosus susceptibility loci, XKR6 and GLT1D1 are associated with childhood-onset SLE in a Korean cohort | 2.8 | 30 | Citations (PDF) |
| 118 | IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis | 3.1 | 150 | Citations (PDF) |
| 119 | Factors associated with development and mortality of pulmonary hypertension in systemic lupus erythematosus patientsLupus, 2018, 27, 1769-1777 | 1.0 | 16 | Citations (PDF) |
| 120 | Comparison of screening strategies for prevalent vertebral fractures in South Korea: vertebral fracture assessment vs. spine radiography | 1.6 | 3 | Citations (PDF) |
| 121 | Comparison of the efficacy and safety of tofacitinib and baricitinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials | 0.7 | 16 | Citations (PDF) |
| 122 | Relationship between cerebral microbleeds and white matter MR hyperintensities in systemic lupus erythematosus: a retrospective observational study | 1.4 | 7 | Citations (PDF) |
| 123 | High Proportion of Subjective Component to the Disease Activity Score is Associated with Favorable Response to Abatacept in Rheumatoid Arthritis | 2.0 | 1 | Citations (PDF) |
| 124 | A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study | 6.8 | 45 | Citations (PDF) |
| 125 | What factors affect discordance between physicians and patients in the global assessment of disease activity in rheumatoid arthritis? | 1.6 | 16 | Citations (PDF) |
| 126 | Safety of resuming biologic DMARDs in patients who develop tuberculosis after anti-TNF treatment | 2.0 | 15 | Citations (PDF) |
| 127 | A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases | 14.9 | 174 | Citations (PDF) |
| 128 | Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab | 2.0 | 11 | Citations (PDF) |
| 129 | Predictors of severe radiographic progression in patients with early rheumatoid arthritis: A Prospective observational cohort study | 0.8 | 12 | Citations (PDF) |
| 130 | Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis | 1.6 | 37 | Citations (PDF) |
| 131 | Confirmation of five novel susceptibility loci for systemic lupus erythematosus (SLE) and integrated network analysis of 82 SLE susceptibility loci. | 2.2 | 51 | Citations (PDF) |
| 132 | CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms | 2.8 | 37 | Citations (PDF) |
| 133 | Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis | 2.0 | 53 | Citations (PDF) |
| 134 | Association between Functional CYP2D6 Polymorphisms and Susceptibility to Autoimmune Diseases: A Meta-Analysis | 1.4 | 15 | Citations (PDF) |
| 135 | Clinical characteristics and outcomes of diffuse alveolar hemorrhage in patients with systemic lupus erythematosus | 2.0 | 40 | Citations (PDF) |
| 136 | The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs | 3.1 | 24 | Citations (PDF) |
| 137 | Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study | 3.1 | 1 | Citations (PDF) |
| 138 | Biological function integrated prediction of severe radiographic progression in rheumatoid arthritis: a nested case control study | 3.1 | 13 | Citations (PDF) |
| 139 | Long-term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation for Refractory Rheumatic Diseases | 1.9 | 1 | Citations (PDF) |
| 140 | Pharmacologic treatment of rheumatoid arthritis | 0.2 | 4 | Citations (PDF) |
| 141 | Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis | 0.7 | 12 | Citations (PDF) |
| 142 | Comparative efficacy and tolerability of monotherapy with leflunomide or tacrolimus for the treatment of rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials | 1.4 | 7 | Citations (PDF) |
| 143 | Brief Report: Influence of HLA-DRB1 Susceptibility Alleles on the Clinical Subphenotypes of Systemic Lupus Erythematosus in Koreans. | 4.8 | 23 | Citations (PDF) |
| 144 | Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans. | 4.8 | 94 | Citations (PDF) |
| 145 | Agreement of Major Diagnosis and Comorbidity between Self-reported Questionnaire and Medical Record Review in Patients with Rheumatic Disease | 1.9 | 1 | Citations (PDF) |
| 146 | Infusion of Human Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Autoimmune Nephritis in a Lupus Model by Suppressing Follicular Helper T-Cell Development | 2.0 | 80 | Citations (PDF) |
| 147 | Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials | 0.8 | 39 | Citations (PDF) |
| 148 | Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture. | 4.8 | 146 | Citations (PDF) |
| 149 | A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach. | 4.8 | 42 | Citations (PDF) |
| 150 | Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data | 2.0 | 21 | Citations (PDF) |
| 151 | Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study | 2.0 | 35 | Citations (PDF) |
| 152 | Association between TYK2 polymorphisms and susceptibility to autoimmune rheumatic diseases: a meta-analysis | 1.0 | 11 | Citations (PDF) |
| 153 | Associations between PTPRC rs10919563 A/G and FCGR2A R131H polymorphisms and responsiveness to TNF blockers in rheumatoid arthritis: a meta-analysis | 2.0 | 32 | Citations (PDF) |
| 154 | Association between functional NLRP3 polymorphisms and susceptibility to autoimmune and inflammatory diseases: a meta-analysisLupus, 2016, 25, 1558-1566 | 1.0 | 24 | Citations (PDF) |
| 155 | The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis | 1.6 | 41 | Citations (PDF) |
| 156 | Contribution of a Non-classical HLA Gene, HLA-DOA, to the Risk of Rheumatoid Arthritis | 4.6 | 81 | Citations (PDF) |
| 157 | Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis | 2.0 | 40 | Citations (PDF) |
| 158 | Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis | 1.6 | 28 | Citations (PDF) |
| 159 | Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis | 2.8 | 25 | Citations (PDF) |
| 160 | Differences in Clinical Features and Mortality between Childhood-onset and Adult-onset Systemic Lupus Erythematosus: A Prospective Single-center Study | 1.3 | 50 | Citations (PDF) |
| 161 | Progress in defining clinically meaningful changes for clinical trials in nonrenal manifestations of SLE disease activity. | 3.1 | 135 | Citations (PDF) |
| 162 | High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry | 14.9 | 227 | Citations (PDF) |
| 163 | A systematic review of diagnostic accuracy of vertebral fracture assessment (VFA) in postmenopausal women and elderly men | 2.8 | 50 | Citations (PDF) |
| 164 | Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production | 6.8 | 15 | Citations (PDF) |
| 165 | Safety and Efficacy of Subcutaneous Golimumab in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: Final 5-year Results of the GO-FORWARD Trial | 1.3 | 42 | Citations (PDF) |
| 166 | Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis | 0.7 | 38 | Citations (PDF) |
| 167 | Discontinuation of etanercept after achievement of sustained remission in patients with rheumatoid arthritis who initially had moderate disease activity—results from the ENCOURAGE study, a prospective, international, multicenter randomized study | 1.6 | 26 | Citations (PDF) |
| 168 | Association between interferon-γ +874 T/A polymorphism and susceptibility to autoimmune diseases: a meta-analysis | 1.0 | 34 | Citations (PDF) |
| 169 | Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA | 6.8 | 10 | Citations (PDF) |
| 170 | The frequency and outcome of lupus nephritis: results from an international inception cohort study. | 1.5 | 517 | Citations (PDF) |
| 171 | Efficacy and safety of methotrexate plus certolizumab pegol or placebo in active rheumatoid arthritis | 0.7 | 3 | Citations (PDF) |
| 172 | Update on the genetic architecture of rheumatoid arthritis | 18.7 | 121 | Citations (PDF) |
| 173 | Associations between eNOS polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis | 0.7 | 5 | Citations (PDF) |
| 174 | Association between shortened telomere length and rheumatoid arthritis | 0.7 | 24 | Citations (PDF) |
| 175 | Correlation between circulating VEGF levels and disease activity in rheumatoid arthritis: a meta-analysis | 0.7 | 40 | Citations (PDF) |
| 176 | Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus | 1.6 | 24 | Citations (PDF) |
| 177 | Glucocorticoid acts differently on vertebral and hip fractures in Korean RA patients using National healthcare claims database | 0.0 | 0 | Citations (PDF) |
| 178 | An HLA-C amino-acid variant in addition to HLA-B*27 confers risk for ankylosing spondylitis in the Korean population | 3.1 | 25 | Citations (PDF) |
| 179 | Interactions between amino acid-defined major histocompatibility complex class II variants and smoking in seropositive rheumatoid arthritis. | 4.8 | 64 | Citations (PDF) |
| 180 | Incidence of Tuberculosis in Rheumatoid Arthritis Patients Using Anti-Tumor Necrosis Factor Agents following Latent Tuberculosis Infection Screening Strategies | 1.9 | 2 | Citations (PDF) |
| 181 | Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents | 0.8 | 11 | Citations (PDF) |
| 182 | Association between FOXP3 polymorphisms and susceptibility to autoimmune diseases: A meta-analysis | 2.5 | 12 | Citations (PDF) |
| 183 | Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials | 2.0 | 15 | Citations (PDF) |
| 184 | The angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to rheumatoid arthritis, vitiligo and psoriasis: A meta-analysis | 5.4 | 27 | Citations (PDF) |
| 185 | Recent advances in systemic lupus erythematosus genetics in an Asian population | 0.8 | 10 | Citations (PDF) |
| 186 | High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci | 6.8 | 103 | Citations (PDF) |
| 187 | People also looked at | 1.7 | 26 | Citations (PDF) |
| 188 | Associations between the functional CD40 rs4810485 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis | 1.0 | 18 | Citations (PDF) |
| 189 | Diagnostic accuracy of anti-MCV and anti-CCP antibodies in rheumatoid arthritis | 0.7 | 37 | Citations (PDF) |
| 190 | Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression. | 4.6 | 35 | Citations (PDF) |
| 191 | Association of joint erosion with SLC22A4 gene polymorphisms inconsistently associated with rheumatoid arthritis susceptibility | 2.5 | 5 | Citations (PDF) |
| 192 | Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations | 0.8 | 34 | Citations (PDF) |
| 193 | Meta-analysis of associations between functional prolactin −1149 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus | 1.4 | 17 | Citations (PDF) |
| 194 | Association between the CTLA-4, CD226, FAS polymorphisms and rheumatoid arthritis susceptibility: A meta-analysis | 0.5 | 16 | Citations (PDF) |
| 195 | Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. | 4.8 | 109 | Citations (PDF) |
| 196 | Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus | 2.0 | 21 | Citations (PDF) |
| 197 | Clinical validation of surface-enhanced Raman scattering-based immunoassays in the early diagnosis of rheumatoid arthritis | 2.7 | 20 | Citations (PDF) |
| 198 | Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus | 1.4 | 11 | Citations (PDF) |
| 199 | Factors Associated with the Use of Complementary and Alternative Medicine for Korean Patients with Rheumatoid Arthritis | 1.3 | 19 | Citations (PDF) |
| 200 | Association between FCGR3B copy number variations and susceptibility to autoimmune diseases: a meta-analysis | 3.4 | 17 | Citations (PDF) |
| 201 | The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. | 2.2 | 77 | Citations (PDF) |
| 202 | Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort | 6.8 | 67 | Citations (PDF) |
| 203 | Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort | 6.8 | 459 | Citations (PDF) |
| 204 | Association between susceptibility to rheumatoid arthritis and PADI4 polymorphisms: a meta-analysis | 1.4 | 31 | Citations (PDF) |
| 205 | Vitamin D receptor FokI, BsmI, and TaqI polymorphisms and susceptibility to rheumatoid arthritis | 0.7 | 28 | Citations (PDF) |
| 206 | Association between the functional MHC2TA −168 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis | 1.4 | 2 | Citations (PDF) |
| 207 | Association of the ABCB1 C3435T polymorphism with responsiveness to and toxicity of DMARDs in rheumatoid arthritis | 0.7 | 20 | Citations (PDF) |
| 208 | Radiologic Changes of Cervical Spine in Ankylosing Spondylitis | 1.4 | 26 | Citations (PDF) |
| 209 | Construction and Application of a Korean Reference Panel for Imputing Classical Alleles and Amino Acids of Human Leukocyte Antigen Genes | 1.6 | 28 | Citations (PDF) |
| 210 | The HLA-DRβ1 amino acid positions 11–13–26 explain the majority of SLE–MHC associations | 11.4 | 98 | Citations (PDF) |
| 211 | Targeted exon sequencing fails to identify rare coding variants with large effect in rheumatoid arthritis | 3.1 | 23 | Citations (PDF) |
| 212 | Development of rheumatoid arthritis specific HLA-DRB1 genotyping microarray | 3.7 | 1 | Citations (PDF) |
| 213 | Meta-Analysis of Associations Between the Peroxisome Proliferator-Activated Receptor-γ Pro12Ala Polymorphism and Susceptibility to Nonalcoholic Fatty Liver Disease, Rheumatoid Arthritis, and Psoriatic Arthritis | 0.6 | 19 | Citations (PDF) |
| 214 | Associations between TRAF1-C5 Gene Polymorphisms and Rheumatoid Arthritis: A Meta-Analysis | 1.4 | 12 | Citations (PDF) |
| 215 | Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations | 2.2 | 73 | Citations (PDF) |
| 216 | Two Functional Lupus-Associated BLK Promoter Variants Control Cell-Type- and Developmental-Stage-Specific Transcription | 4.6 | 59 | Citations (PDF) |
| 217 | Validité et le rôle du dans la détection des fractures vertébrales prévalentes chez les patients atteints de polyarthrite rhumatoïde | 0.0 | 0 | Citations (PDF) |
| 218 | The frequency of single nucleotide polymorphisms and their association with uric acid concentration based on data from genome-wide association studies in the Korean population | 2.0 | 5 | Citations (PDF) |
| 219 | Meta-analysis of gene expression profiles to predict response to biologic agents in rheumatoid arthritis | 1.4 | 8 | Citations (PDF) |
| 220 | Gene–environmental interaction between smoking and shared epitope on the development of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: a meta-analysis | 0.8 | 18 | Citations (PDF) |
| 221 | Lymphoma risk in systemic lupus: effects of disease activity versus treatment | 6.8 | 129 | Citations (PDF) |
| 222 | SERS-based immunoassay of anti-cyclic citrullinated peptide for early diagnosis of rheumatoid arthritis† | 4.0 | 20 | Citations (PDF) |
| 223 | Biologic discontinuation studies: a systematic review of methods | 6.8 | 44 | Citations (PDF) |
| 224 | Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. | 2.2 | 144 | Citations (PDF) |
| 225 | Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease | 6.8 | 30 | Citations (PDF) |
| 226 | Improving Participation in Clinical Trials of Novel Therapies | 0.9 | 4 | Citations (PDF) |
| 227 | Liver X receptors alpha gene (NR1H3) promoter polymorphisms are associated with systemic lupus erythematosus in Koreans | 3.1 | 17 | Citations (PDF) |
| 228 | Meta-analysis of functional MBL polymorphisms | 0.7 | 10 | Citations (PDF) |
| 229 | Functional FCGR3A 158 V/F and IL-6 −174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis | 2.0 | 34 | Citations (PDF) |
| 230 | Associations between functional TNFR2 196 M/R polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis | 2.0 | 10 | Citations (PDF) |
| 231 | Coffee or tea consumption and the risk of rheumatoid arthritis: a meta-analysis | 1.4 | 81 | Citations (PDF) |
| 232 | Validity and role of vertebral fracture assessment in detecting prevalent vertebral fracture in patients with rheumatoid arthritis | 1.9 | 10 | Citations (PDF) |
| 233 | Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis | 1.4 | 46 | Citations (PDF) |
| 234 | Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study | 2.0 | 23 | Citations (PDF) |
| 235 | Meta-analysis of SLC22A4 and RUNX1 polymorphisms | 0.7 | 7 | Citations (PDF) |
| 236 | Association between the functional ITGAM rs1143679 G/A polymorphism and systemic lupus erythematosus/lupus nephritis or rheumatoid arthritis: an update meta-analysis | 2.0 | 20 | Citations (PDF) |
| 237 | The association between susceptibility to inflammatory arthritis and miR-146a, miR-499 and IRAK1 polymorphisms | 0.7 | 22 | Citations (PDF) |
| 238 | The miR-146a polymorphism and susceptibility to systemic lupus erythematosus and rheumatoid arthritis | 0.7 | 15 | Citations (PDF) |
| 239 | Meta-analysis of associations between functional HLA-G polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis | 2.0 | 25 | Citations (PDF) |
| 240 | Meta-analysis of the association between functional MICA-TM polymorphisms and systemic lupus erythematosus, rheumatoid arthritis and ankylosing spondylitis | 0.7 | 5 | Citations (PDF) |
| 241 | Meta-analysis of genetic polymorphisms in programmed cell death 1 | 0.7 | 52 | Citations (PDF) |
| 242 | Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis | 1.6 | 35 | Citations (PDF) |
| 243 | Factors associated with gout in South Koreans: analysis using the National Health Insurance Corporation and the National Health Screening Exam databases | 1.4 | 16 | Citations (PDF) |
| 244 | Interferon-gamma release assays versus tuberculin skin testing in patients with rheumatoid arthritis | 0.8 | 5 | Citations (PDF) |
| 245 | Endothelial nitric oxide synthase gene polymorphisms and the risk of osteonecrosis of the femoral head in systemic lupus erythematosus | 1.6 | 21 | Citations (PDF) |
| 246 | The PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis | 2.0 | 21 | Citations (PDF) |
| 247 | Cancer risk in systemic lupus: An updated international multi-centre cohort study | 3.9 | 272 | Citations (PDF) |
| 248 | Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. | 6.5 | 100 | Citations (PDF) |
| 249 | Interleukin-4, interleukin-4 receptor, and interleukin-18 polymorphisms and rheumatoid arthritis: a meta-analysis | 1.4 | 10 | Citations (PDF) |
| 250 | Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database | 2.0 | 99 | Citations (PDF) |
| 251 | Association of an activity-enhancing variant of IRAK1 and an MECP2-IRAK1 haplotype with increased susceptibility to rheumatoid arthritis. | 6.5 | 30 | Citations (PDF) |
| 252 | Association between functional Fc receptor-like 3 (FCRL3) −169 C/T polymorphism and susceptibility to seropositive rheumatoid arthritis in Asians: A meta-analysis | 0.5 | 8 | Citations (PDF) |
| 253 | Factors Influencing Discrepancies Between the QuantiFERON-TB Gold in Tube Test and the Tuberculin Skin Test in Korean Patients with Rheumatic Diseases | 2.0 | 29 | Citations (PDF) |
| 254 | Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea | 3.5 | 54 | Citations (PDF) |
| 255 | Relation of rheumatoid factor and anti-cyclic citrullinated peptide antibody with disease activity in rheumatoid arthritis: cross-sectional study | 2.0 | 12 | Citations (PDF) |
| 256 | Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs | 0.8 | 80 | Citations (PDF) |
| 257 | Golimumab in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results Through 2 Years of the GO-FORWARD Study Extension | 1.3 | 39 | Citations (PDF) |
| 258 | Association of genetic polymorphisms in CD40 with susceptibility to SLE in the Korean population. | 1.5 | 19 | Citations (PDF) |
| 259 | Interaction of HLA-DRB1*09:01 and *04:05 with Smoking Suggests Distinctive Mechanisms of Rheumatoid Arthritis Susceptibility Beyond the Shared Epitope | 1.3 | 14 | Citations (PDF) |
| 260 | Association between the chemokine receptor 5 delta32 polymorphism and rheumatoid arthritis: a meta-analysis | 1.6 | 16 | Citations (PDF) |
| 261 | Diagnosis and Treatment of Lupus Nephritis: Survey Results on Four Important Issues | 1.9 | 1 | Citations (PDF) |
| 262 | Longterm Safety and Efficacy of Abatacept in Koreans with Rheumatoid Arthritis | 1.9 | 1 | Citations (PDF) |
| 263 | Toll-like receptor polymorphisms and rheumatoid arthritis: a systematic review | 2.0 | 23 | Citations (PDF) |
| 264 | Prevalence and incidence of systemic lupus erythematosus in South Korea | 2.0 | 43 | Citations (PDF) |
| 265 | Association between TNF-α promoter –308 A/G polymorphism and rheumatoid arthritis: a meta-analysis | 2.0 | 19 | Citations (PDF) |
| 266 | Genetics of rheumatoid arthritis contributes to biology and drug discovery | 32.8 | 1,942 | Citations (PDF) |
| 267 | Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study | 6.8 | 150 | Citations (PDF) |
| 268 | Omega-3 Polyunsaturated Fatty Acids and the Treatment of Rheumatoid Arthritis: A Meta-analysis | 1.9 | 151 | Citations (PDF) |
| 269 | Mortality and Incidence of Malignancy in Korean Patients with Rheumatoid Arthritis | 1.3 | 32 | Citations (PDF) |
| 270 | Associations between the FAS −670 A/G and −1,377 G/A polymorphisms and susceptibility to autoimmune rheumatic diseases: a meta-analysis | 2.0 | 10 | Citations (PDF) |
| 271 | Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis | 2.0 | 89 | Citations (PDF) |
| 272 | Associations between interleukin-23 receptor polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis | 2.0 | 19 | Citations (PDF) |
| 273 | The glutathione S-transferase M1 and P1 polymorphisms and rheumatoid arthritis: a meta-analysis | 2.0 | 10 | Citations (PDF) |
| 274 | Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis | 14.9 | 833 | Citations (PDF) |
| 275 | Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. | 6.5 | 4,349 | Citations (PDF) |
| 276 | The association between the functional PTPN22 1858 C/T and MIF −173 C/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis | 3.4 | 24 | Citations (PDF) |
| 277 | Associations between TNFAIP3 gene polymorphisms and rheumatoid arthritis: a meta-analysis | 3.4 | 44 | Citations (PDF) |
| 278 | The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis | 3.4 | 34 | Citations (PDF) |
| 279 | TNF promoter −308 A/G and −238 A/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis | 2.0 | 9 | Citations (PDF) |
| 280 | Does brachydactyly have a protective effect on the erosive changes in rheumatoid arthritis? | 1.9 | 2 | Citations (PDF) |
| 281 | Korean Observational Study Network for Arthritis (KORONA): Establishment of a Prospective Multicenter Cohort for Rheumatoid Arthritis in South Korea | 2.0 | 52 | Citations (PDF) |
| 282 | Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. | 2.3 | 277 | Citations (PDF) |
| 283 | Associations between interferon regulatory factor 5 polymorphisms and rheumatoid arthritis: a meta-analysis | 2.0 | 5 | Citations (PDF) |
| 284 | Prevalence and incidence of rheumatoid arthritis in South Korea | 2.0 | 58 | Citations (PDF) |
| 285 | Factors influencing quality of life (QOL) for Korean patients with rheumatoid arthritis (RA) | 2.0 | 38 | Citations (PDF) |
| 286 | Association between the chemokine receptor 5 delta32 polymorphism and rheumatoid arthritis: a meta-analysis | 1.6 | 8 | Citations (PDF) |
| 287 | Tuberculous cellulitis as a manifestation of miliary tuberculosis in a patient with malignancy-associated dermatomyositis | 1.6 | 11 | Citations (PDF) |
| 288 | Impact of Change in Reimbursement Guideline of Rheumatoid Arthritis on the Short Term Persistence of Tumor Necrosis Factor (TNF) Blockers | 1.9 | 4 | Citations (PDF) |
| 289 | Treatment Persistence with TNF Blocker in Korean Rheumatoid Arthritis Patients | 1.9 | 2 | Citations (PDF) |
| 290 | A Case of Primary Influenza B Pneumonia in Lupus Nephritis Patient on Immunosuppressive Treatment | 1.9 | 0 | Citations (PDF) |
| 291 | Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort | 2.1 | 257 | Citations (PDF) |
| 292 | Genome-wide association study of rheumatoid arthritis in Koreans: population-specific loci as well as overlap with European susceptibility loci. | 6.5 | 118 | Citations (PDF) |
| 293 | Incidence of Tuberculosis Among Korean Patients with Ankylosing Spondylitis Who Are Taking Tumor Necrosis Factor Blockers | 1.3 | 43 | Citations (PDF) |
| 294 | Replicated association of a regulatory polymorphism in the interferon γ gene with lupus susceptibility | 6.8 | 3 | Citations (PDF) |
| 295 | Impact of comorbidities on TNF inhibitor persistence in rheumatoid arthritis patients: an analysis of Korean National Health Insurance claims data | 2.0 | 24 | Citations (PDF) |
| 296 | Association between the CTLA-4 +49 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis | 2.0 | 16 | Citations (PDF) |
| 297 | Methylenetetrahydrofolate reductase polymorphisms, C677T and A1298C, are associated with methotrexate-related toxicities in Korean patients with rheumatoid arthritis | 2.0 | 24 | Citations (PDF) |
| 298 | Different genetic effect of PXK on systemic lupus erythematosus in the Korean population | 2.0 | 7 | Citations (PDF) |
| 299 | Evaluation of disease activity indices in Korean patients with rheumatoid arthritis | 2.0 | 12 | Citations (PDF) |
| 300 | Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis | 2.0 | 42 | Citations (PDF) |
| 301 | The association between the PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis update | 2.0 | 16 | Citations (PDF) |
| 302 | Prevalence and factors affecting glucosamine use in Korea: a survey-based study | 2.0 | 8 | Citations (PDF) |
| 303 | International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? | 1.3 | 574 | Citations (PDF) |
| 304 | Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. | 6.5 | 120 | Citations (PDF) |
| 305 | Validity of Estimating EuroQol (EQ5D) from a Health Assessment Questionnaire (HAQ) | 0.1 | 1 | Citations (PDF) |
| 306 | The Current Status of Surveys on Prevalence of Rheumatic Diseases in Korea | 0.1 | 10 | Citations (PDF) |
| 307 | Rheumatoid arthritis: past, present and future | 0.2 | 1 | Citations (PDF) |
| 308 | Epidemiology and etiology of rheumatoid arthritis | 0.2 | 7 | Citations (PDF) |
| 309 | Associations Between Tumor Necrosis Factor-α (TNF-α) −308 and −238 G/A Polymorphisms and Shared Epitope Status and Responsiveness to TNF-α Blockers in Rheumatoid Arthritis: A Metaanalysis Update | 1.3 | 53 | Citations (PDF) |
| 310 | Adverse events in analgesic treatment with tramadol associated with CYP2D6 extensive-metaboliser and OPRM1 high-expression variants | 6.8 | 28 | Citations (PDF) |
| 311 | Interferon-gamma gene polymorphisms associated with susceptibility to systemic lupus erythematosus | 6.8 | 77 | Citations (PDF) |
| 312 | Possible Reactivation of Potential Hepatitis B Virus Occult Infection by Tumor Necrosis Factor-α Blocker in the Treatment of Rheumatic Diseases | 1.3 | 55 | Citations (PDF) |
| 313 | Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study | 6.8 | 131 | Citations (PDF) |
| 314 | Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study | 3.1 | 36 | Citations (PDF) |
| 315 | Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis | 2.0 | 139 | Citations (PDF) |
| 316 | The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials | 2.0 | 69 | Citations (PDF) |
| 317 | Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis | 2.0 | 18 | Citations (PDF) |
| 318 | Lack of association between Poly(ADP-ribose) polymerase (PARP) polymorphisms and rheumatoid arthritis in a Korean population | 2.0 | 7 | Citations (PDF) |
| 319 | TNF Inhibitors and Uveitis in Ankylosing Spondylitis | 0.1 | 1 | Citations (PDF) |
| 320 | Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. | 6.5 | 104 | Citations (PDF) |
| 321 | TRAF1 polymorphisms associated with rheumatoid arthritis susceptibility in Asians and in Caucasians. | 6.5 | 43 | Citations (PDF) |
| 322 | CD244 is not associated with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in a Korean population. | 6.5 | 7 | Citations (PDF) |
| 323 | No association between interleukin 23 receptor gene polymorphisms and systemic lupus erythematosus | 2.0 | 20 | Citations (PDF) |
| 324 | Ulnar artery vasculopathy in systemic sclerosis | 2.0 | 40 | Citations (PDF) |
| 325 | Genetic associations of LYN with systemic lupus erythematosus | 2.1 | 90 | Citations (PDF) |
| 326 | Genetic studies of systemic lupus erythematosus in Asia: where are we now? | 2.1 | 31 | Citations (PDF) |
| 327 | A regulatory SNP at position −899 in CDKN1A is associated with systemic lupus erythematosus and lupus nephritis | 2.1 | 21 | Citations (PDF) |
| 328 | Dietary Vitamin E and Quercetin Modulate Inflammatory Responses of Collagen-Induced Arthritis in Mice | 1.2 | 35 | Citations (PDF) |
| 329 | CYP1A2 genotype and rheumatoid arthritis in Koreans | 2.0 | 9 | Citations (PDF) |
| 330 | Etanercept treatment in rheumatoid arthritis patients with chronic kidney failure on predialysis | 2.0 | 10 | Citations (PDF) |
| 331 | Characteristics of Korean Patients with RA: A Single Center Cohort Study | 0.1 | 10 | Citations (PDF) |
| 332 | Putative Role of Functional Interferon Regulatory Factor 5 (IRF5) Polymorphism in Rheumatoid Arthritis in a Korean Population | 1.3 | 31 | Citations (PDF) |
| 333 | The reliability and validity of a Korean translation of the BASDAI in Korean patients with ankylosing spondylitis. | 1.0 | 8 | Citations (PDF) |
| 334 | Associations of DNase IV polymorphisms with autoantibodies in patients with systemic lupus erythematosus. | 1.5 | 9 | Citations (PDF) |
| 335 | The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case–cohort study | 6.8 | 141 | Citations (PDF) |
| 336 | The Prevalence and Trend of Arthritis in Korea: Results from Korea National Health and Nutrition Examination Surveys | 0.1 | 34 | Citations (PDF) |
| 337 | A Case of Recurrent Intestinal Pseudo-obstruction in a Patient with Systemic Lupus Erythematosus | 0.1 | 0 | Citations (PDF) |
| 338 | Different Genetic Effects of Interferon Regulatory Factor 5 (IRF5) Polymorphisms on Systemic Lupus Erythematosus in a Korean Population | 1.3 | 17 | Citations (PDF) |
| 339 | Lack of association between interleukin 23 receptor gene polymorphisms and rheumatoid arthritis susceptibility | 2.0 | 19 | Citations (PDF) |
| 340 | A Case of Systemic Lupus Erythematosus Patient with Ulcerative Colitis | 0.1 | 2 | Citations (PDF) |
| 341 | MERTK polymorphisms associated with risk of haematological disorders among Korean SLE patients. | 1.5 | 21 | Citations (PDF) |
| 342 | Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population | 3.1 | 54 | Citations (PDF) |
| 343 | Interleukin‐1β and interleukin‐1 receptor antagonist gene polymorphisms in Korean patients with adult‐onset Still's disease | 0.6 | 17 | Citations (PDF) |
| 344 | Association of STAT4 with Rheumatoid Arthritis in the Korean Population | 4.6 | 154 | Citations (PDF) |
| 345 | Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis. | 6.5 | 46 | Citations (PDF) |
| 346 | Effect of lower dose intravenous cyclophosphamide on remission induction in Korean patients with lupus nephritis | 2.0 | 4 | Citations (PDF) |
| 347 | TREX1 polymorphisms associated with autoantibodies in patients with systemic lupus erythematosus | 2.0 | 16 | Citations (PDF) |
| 348 | Anti-TNF-α Therapy in Rheumatic Diseases with Chronic Hepatitis B Virus Infection | 0.1 | 1 | Citations (PDF) |
| 349 | Severe Leukopenia after Intravenous Cyclophosphamide Pulse Therapy in a Patient Having Cytochrome P450 2A6*1B | 0.1 | 0 | Citations (PDF) |
| 350 | Clinical experience with tumor necrosis factor blockers in Korean rheumatoid arthritis patients | 0.3 | 4 | Citations (PDF) |
| 351 | Cyclooxygenase-2 polymorphisms and risk of systemic lupus erythematosus in Koreans | 2.0 | 6 | Citations (PDF) |
| 352 | A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. | 6.5 | 142 | Citations (PDF) |
| 353 | Mortality in systemic lupus erythematosus. | 6.5 | 921 | Citations (PDF) |
| 354 | The -169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans. | 6.5 | 35 | Citations (PDF) |
| 355 | Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus. | 1.5 | 18 | Citations (PDF) |
| 356 | Poly(ADP-ribose) polymerase (PARP) polymorphisms associated with nephritis and arthritis in systemic lupus erythematosus. | 1.5 | 29 | Citations (PDF) |
| 357 | Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus | 0.6 | 73 | Citations (PDF) |
| 358 | DNase II polymorphisms associated with risk of renal disorder among systemic lupus erythematosus patients | 1.4 | 34 | Citations (PDF) |
| 359 | Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases | 1.9 | 252 | Citations (PDF) |
| 360 | Letter to the Editor | 1.0 | 4 | Citations (PDF) |
| 361 | Catalase and PPARg2 genotype and risk of systemic lupus erythematosus in Koreans | 1.0 | 14 | Citations (PDF) |
| 362 | Glutathione S-transferase genotype and risk of systemic lupus erythematosus in Koreans | 1.0 | 25 | Citations (PDF) |
| 363 | Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang Lupus Cohort in Seoul, Korea | 1.0 | 43 | Citations (PDF) |
| 364 | The mechanism of low-concentration sodium nitroprusside-mediated protection of chondrocyte death | 3.1 | 28 | Citations (PDF) |
| 365 | Catalase and PPARγ2 genotype and risk of rheumatoid arthritis in Koreans | 2.0 | 19 | Citations (PDF) |
| 366 | Drug Utilization Review: Economical Aspect | 0.2 | 1 | Citations (PDF) |
| 367 | Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients. | 2.2 | 65 | Citations (PDF) |
| 368 | Association analyses of DNA methyltransferase-1 (DNMT1) polymorphisms with systemic lupus erythematosus | 1.4 | 25 | Citations (PDF) |
| 369 | Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1*0405 and *0901. | 6.5 | 107 | Citations (PDF) |
| 370 | Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy | 2.0 | 6 | Citations (PDF) |
| 371 | Current Scope and Perspective of Burden of Disease Study based on Health Related Quality of Life | 0.0 | 6 | Citations (PDF) |
| 372 | Identification of a novel DRB1*04 allele: DRB1*0445 | 0.6 | 4 | Citations (PDF) |
| 373 | The ACR classification of neuropsychiatric systemic lupus erythematosus: how this helps in diagnosis and treatment | 0.3 | 4 | Citations (PDF) |
| 374 | Pharmacoeconomic analysis of thiopurine methyltransferase polymorphism screening by polymerase chain reaction for treatment with azathioprine in Korea. | 1.5 | 61 | Citations (PDF) |
| 375 | Glutathione S-transferase M1, T1, and P1 gene polymorphisms and carotid atherosclerosis in Korean patients with rheumatoid arthritis | 2.0 | 14 | Citations (PDF) |
| 376 | Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis | 2.0 | 16 | Citations (PDF) |
| 377 | Impaired antioxidant status and decreased dietary intake of antioxidants in patients with systemic lupus erythematosus | 2.0 | 40 | Citations (PDF) |
| 378 | Induction of Remission with Intravenous Immunoglobulin and Cyclophosphamide in Steroid-Resistant Evans’ Syndrome Associated with Dermatomyositis | 1.4 | 15 | Citations (PDF) |
| 379 | Cross-cultural adaptation and validation of Korean Western Ontario and McMaster Universities (WOMAC) and Lequesne osteoarthritis indices for clinical research. | 4.2 | 160 | Citations (PDF) |
| 380 | Methodological issues of corticosteroid use in SLE clinical trials | 1.0 | 11 | Citations (PDF) |
| 381 | The epidemiology of systemic lupus erythematosus in populations of African ancestry: A critical review of the “prevalence gradient hypothesis” | 6.5 | 118 | Citations (PDF) |
| 382 | A Rare Diagnosis of Infiltrative Muscle Disease in a Patient With Multiple Joint Pain and Fever | 1.3 | 0 | Citations (PDF) |
| 383 | Tracking clonal dynamics of CD8 T cells and immune dysregulation in progression of systemic lupus erythematosus with nephritis | 10.1 | 9 | Citations (PDF) |
| 384 | Prevalence, determinants and outcomes of low disease activity and remission attainment in SLE patients with clinically active disease | 2.3 | 0 | Citations (PDF) |
| 385 | Integrative spatial multiomics analysis reveals regulatory mechanisms of VCAM1+ proximal tubule cells in lupus nephritis | 6.8 | 9 | Citations (PDF) |
| 386 | Predictors of damage accrual by organ domain in systemic lupus erythematosus Open Access | 1.5 | 3 | Citations (PDF) |
| 387 | Imputation disparities driven by recent selection and their impact on disease risk estimation in East and Southeast Asian populations | 3.3 | 1 | Citations (PDF) |
| 388 | Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug Monitoring | 4.8 | 7 | Citations (PDF) |
| 389 | Mucocutaneous Disease Activity and Damage Accrual in Systemic Lupus Erythematosus: Analyses From the Asia-Pacific Lupus Collaboration Longitudinal Cohort Study | 2.3 | 0 | Citations (PDF) |
| 390 | Predictive correlates of arthritis and joint damage in systemic lupus erythematosus: a multinational prospective cohort study. | 1.5 | 0 | Citations (PDF) |
| 391 | Increased Risk of Intrahepatic Cholestasis of Pregnancy in Women With Systemic Lupus Erythematosus Exposed to Azathioprine. | 4.8 | 0 | Citations (PDF) |
| 392 | Safety and Effectiveness of Intravenous Belimumab in Patients with Systemic Lupus Erythematosus in South Korea: A Multicentre, Observational, Real-World Study. | 1.1 | 0 | Citations (PDF) |
